Stay updated on Secukinumab in Psoriatic Arthritis: Clinical Trial
Sign up to get notified when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.

Latest updates to the Secukinumab in Psoriatic Arthritis: Clinical Trial page
- Check6 days agoChange DetectedFooter revision updated from v3.3.1 to v3.3.2. This UI/backend update does not alter study content.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Publications section description was updated to reflect that entries are automatically filled from PubMed and may not pertain to the study; version updated to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedSite-wide government funding status notice was removed from the page. This change does not affect the study details, eligibility criteria, or other core content.SummaryDifference0.2%

- Check35 days agoChange DetectedNo substantive changes were detected in the Study Details page between the two screenshots; core content such as the title, conditions, interventions, outcomes, eligibility criteria, and locations remains unchanged, with only minor formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check71 days agoChange DetectedAdded version label v3.1.0 and removed multiple drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) along with an older revision reference (v3.0.2); content now omits several core safety sections. If these deletions are intended, this is a major reduction in detailed drug-safety content.SummaryDifference0.3%

Stay in the know with updates to Secukinumab in Psoriatic Arthritis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab in Psoriatic Arthritis: Clinical Trial page.